Clever Gomes Cardoso
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Clever Gomes Cardoso has a total of 101 co-authors. Here are the top co-authors by number of shared publications:
- Lee Chen-Chen
Federal University of Goiás
7 shared publications - Abel Vieira de Melo Bisneto
Department of Genetics, Laboratory of Radiobiology and Mutagenesis, Av. Esperança s/n, Campus Samambaia, Federal University of Goiás , Goiânia , Goiás, 74690-900
5 shared publications - Jefferson Hollanda Véras
Institute of Biological Sciences, Federal University of Goiás, Goiânia-GO, Brazil
5 shared publications - Amanda Silva Fernandes
Pontifical Catholic University of Goiás
4 shared publications - Cristiene Costa Carneiro
Pontificia Universidade Catolica de Goias
4 shared publications - Elisa Flávia Luiz Cardoso Bailão
Central Campus, State University of Goiás
4 shared publications
Latest Publications
- Open Access
- 3 November 2025
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 10 (45) , 54009-54021
Development of Alginate/Carboxymethylcellulose Films Incorporated with Canavalia ensiformis Lectin (ConA) with Angiogenic Properties
The development of new materials for wound care is a critical area, focused on creating dressings with improved properties, such as high absorption, flexibility, and low cost. In this context, natural polymers such as alginate and carboxymethyl cellulose (CMC) emerge as promising choices, given their biodegradability and their ability to promote an ideal healing environment. Concomitantly, lectins with angiogenic potential have been extensively investigated for their ability to modulate cellular responses and induce the formation of new blood vessels. This research aims to incorporate the lectin from Canavalia ensiformis (ConA) into alginate and carboxymethylcellulose (CMC) films to promote blood vessel growth and induce revascularization as a therapeutic approach. Film characterization and physicochemical tests showed efficient lectin/film incorporation, as observed through differential scanning calorimetry (DSC) analysis and Fourier-transform infrared spectroscopy (FTIR). DSC analysis showed that alginate/CMC films with ConA tend to retain less water, volatilizing more easily, with a temperature difference of 94 and 81 °C to 69 and 77 °C films containing ConA. In addition to the significantly prolonged retention capacity of ConA in the film, FTIR data suggest that ConA is anchored in the alginate matrix due to the cross-linked nature of the film chain, with minimal chemical interactions (or chemical bonds). Analysis of hemagglutinating activity and immunohistochemical assays showed an increase in the expression of the angiogenic factors TGF-β and VEGF. These results indicate that the biopolymers used are an effective alternative for wound treatment, pointing to future research into the development of therapeutic biofilms.
- 3 November 2025
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 10 (45) , 54009-54021
Open AccessDevelopment of Alginate/Carboxymethylcellulose Films Incorporated with Canavalia ensiformis Lectin (ConA) with Angiogenic Properties
The development of new materials for wound care is a critical area, focused on creating dressings with improved properties, such as high absorption, flexibility, and low cost. In this context, natural polymers such as alginate and carboxymethyl cellulose (CMC) emerge as promising choices, given their biodegradability and their ability to promote an ideal healing environment. Concomitantly, lectins with angiogenic potential have been extensively investigated for their ability to modulate cellular responses and induce the formation of new blood vessels. This research aims to incorporate the lectin from Canavalia ensiformis (ConA) into alginate and carboxymethylcellulose (CMC) films to promote blood vessel growth and induce revascularization as a therapeutic approach. Film characterization and physicochemical tests showed efficient lectin/film incorporation, as observed through differential scanning calorimetry (DSC) analysis and Fourier-transform infrared spectroscopy (FTIR). DSC analysis showed that alginate/CMC films with ConA tend to retain less water, volatilizing more easily, with a temperature difference of 94 and 81 °C to 69 and 77 °C films containing ConA. In addition to the significantly prolonged retention capacity of ConA in the film, FTIR data suggest that ConA is anchored in the alginate matrix due to the cross-linked nature of the film chain, with minimal chemical interactions (or chemical bonds). Analysis of hemagglutinating activity and immunohistochemical assays showed an increase in the expression of the angiogenic factors TGF-β and VEGF. These results indicate that the biopolymers used are an effective alternative for wound treatment, pointing to future research into the development of therapeutic biofilms.
- Open Access
- 31 October 2025
- Published by American Chemical Society (ACS) in ACS Applied Nano Materials
- Vol. 8 (45) , 21774-21787
Nearly Real-Time Monitoring of Magnetic Nanoparticle-Mediated Photothermal Therapy by MRI-Based Proton Resonance Frequency Thermometry
- 31 October 2025
- Published by American Chemical Society (ACS) in ACS Applied Nano Materials
- Vol. 8 (45) , 21774-21787
Open AccessNearly Real-Time Monitoring of Magnetic Nanoparticle-Mediated Photothermal Therapy by MRI-Based Proton Resonance Frequency Thermometry
- Open Access
- 8 October 2025
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 10 (41) , 49148-49157
Lectin from Vatairea macrocarpa (Benth.) Ducke Exhibits Selective Cytotoxicity and Angiogenesis Inhibition in Lung Cancer Cells
Angiogenesis plays a vital role in tumor development, and its inhibition, along with selective cytotoxicity, represents a promising strategy for cancer treatment. Lectins, carbohydrate-binding proteins, have demonstrated dual potential in blocking angiogenesis and selectively targeting tumor cells. This study investigates the antiangiogenic and cytotoxic properties of Vatairea macrocarpa lectin (VML) through the chorioallantoic membrane (CAM) assay and tests on normal VERO cells and tumor cell lines A549, SH-SY5Y, S180, and B16-F10. VML exhibited selective cytotoxicity exclusively against A549 lung carcinoma cells, with an IC50 of 97.21 μg/mL, showing no significant toxicity to other lines. In the CAM assay, VML significantly inhibited neovascularization triggered by A549 cells, reaching 70.38% inhibition at 100 μg/mL. Immunohistochemical analyses confirmed the suppression of angiogenesis by showing decreased expression of VEGF and TGF-β. Histological assessments also revealed reductions in new vessel formation, inflammatory cell infiltration, fibroblast presence, and membrane thickening. These results highlight VML’s dual role in inhibiting angiogenesis and exerting selective cytotoxicity, likely due to its specific interaction with tumor-associated carbohydrates. Consequently, VML emerges as a potential candidate for targeted cancer therapy or as a complementary therapeutic agent. Further research is necessary to fully understand the molecular mechanisms underlying its antitumor activity.
- 8 October 2025
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 10 (41) , 49148-49157
Open AccessLectin from Vatairea macrocarpa (Benth.) Ducke Exhibits Selective Cytotoxicity and Angiogenesis Inhibition in Lung Cancer Cells
Angiogenesis plays a vital role in tumor development, and its inhibition, along with selective cytotoxicity, represents a promising strategy for cancer treatment. Lectins, carbohydrate-binding proteins, have demonstrated dual potential in blocking angiogenesis and selectively targeting tumor cells. This study investigates the antiangiogenic and cytotoxic properties of Vatairea macrocarpa lectin (VML) through the chorioallantoic membrane (CAM) assay and tests on normal VERO cells and tumor cell lines A549, SH-SY5Y, S180, and B16-F10. VML exhibited selective cytotoxicity exclusively against A549 lung carcinoma cells, with an IC50 of 97.21 μg/mL, showing no significant toxicity to other lines. In the CAM assay, VML significantly inhibited neovascularization triggered by A549 cells, reaching 70.38% inhibition at 100 μg/mL. Immunohistochemical analyses confirmed the suppression of angiogenesis by showing decreased expression of VEGF and TGF-β. Histological assessments also revealed reductions in new vessel formation, inflammatory cell infiltration, fibroblast presence, and membrane thickening. These results highlight VML’s dual role in inhibiting angiogenesis and exerting selective cytotoxicity, likely due to its specific interaction with tumor-associated carbohydrates. Consequently, VML emerges as a potential candidate for targeted cancer therapy or as a complementary therapeutic agent. Further research is necessary to fully understand the molecular mechanisms underlying its antitumor activity.
- Open Access
- 30 June 2025
- Published by Fiocruz - Instituto de Tecnologia em Farmacos in Revista Fitos
- Vol. 19 (1) , e1812
Atividade antiproliferativa do composto bioativo de Silybum marianum em linhagem celular de melanoma humano com mutação BRAF: potencial para reposicionamento terapêutico
This study investigated the in vitro antiproliferative potential of Silibinin on human melanoma cells with a BRAF gene mutation. Cell viability was assessed through incubation with different concentrations (41, 104, 207, and 518 µM) for 48 hours, using the MTT assay (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide), which involves the reduction of the tetrazolium salt. The inhibitory concentration (IC50) was determined to be 240 µM. Bright-field microscopy revealed loss of cell adhesion to the substrate, a characteristic feature of cell death by apoptosis, across the tested doses. These results highlight the need for further studies to elucidate the mechanism of action and confirm its clinical efficacy.
- 30 June 2025
- Published by Fiocruz - Instituto de Tecnologia em Farmacos in Revista Fitos
- Vol. 19 (1) , e1812
Open AccessAtividade antiproliferativa do composto bioativo de Silybum marianum em linhagem celular de melanoma humano com mutação BRAF: potencial para reposicionamento terapêutico
This study investigated the in vitro antiproliferative potential of Silibinin on human melanoma cells with a BRAF gene mutation. Cell viability was assessed through incubation with different concentrations (41, 104, 207, and 518 µM) for 48 hours, using the MTT assay (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide), which involves the reduction of the tetrazolium salt. The inhibitory concentration (IC50) was determined to be 240 µM. Bright-field microscopy revealed loss of cell adhesion to the substrate, a characteristic feature of cell death by apoptosis, across the tested doses. These results highlight the need for further studies to elucidate the mechanism of action and confirm its clinical efficacy.
- Open Access
- 31 December 2024
- Published by Sociedade Brasileira de Plantas Medicinais in Revista Brasileira de Plantas Medicinais
- Vol. 26 (1) , 11-19
Angiogenic potential of “Quina do Cerrado” (Strychnos pseudoquina)
Leaf and bark infusions of the Strychnos pseudoquina A.St.-Hil., Loganiaceae, plant have long been used in Brazilian traditional medicine for the treatment of various diseases and medical conditions, showing apparent antipyretic, gastric cicatrizant, and especially antimalarial effects. The literature contains abundant reports of plants that possess bioactive components with therapeutic properties. The search for natural substances that promote or inhibit angiogenesis is the focus of current research, since numerous drugs derived from plants have these effects. Thus, in this study, we investigated the angiogenic potential of S. pseudoquina, using the embryonated chicken egg chorioallantoic membrane assay for the angiogenesis tests. Three concentrations of an aqueous extract of S. pseudoquina bark were tested: 15, 30, and 60 mg/ml. The mean percentages of vascularization of CAMs treated with these three extract concentrations were 15.4%, 17.1%, and 17.2%, respectively, which were significantly higher (p<0.05) than that in the negative (8.9%) and inhibitor controls (2.2%). Therefore, it was concluded that the aqueous extract of S. pseudoquina can promote angiogenesis at the concentrations tested.
- 31 December 2024
- Published by Sociedade Brasileira de Plantas Medicinais in Revista Brasileira de Plantas Medicinais
- Vol. 26 (1) , 11-19
Open AccessAngiogenic potential of “Quina do Cerrado” (Strychnos pseudoquina)
Leaf and bark infusions of the Strychnos pseudoquina A.St.-Hil., Loganiaceae, plant have long been used in Brazilian traditional medicine for the treatment of various diseases and medical conditions, showing apparent antipyretic, gastric cicatrizant, and especially antimalarial effects. The literature contains abundant reports of plants that possess bioactive components with therapeutic properties. The search for natural substances that promote or inhibit angiogenesis is the focus of current research, since numerous drugs derived from plants have these effects. Thus, in this study, we investigated the angiogenic potential of S. pseudoquina, using the embryonated chicken egg chorioallantoic membrane assay for the angiogenesis tests. Three concentrations of an aqueous extract of S. pseudoquina bark were tested: 15, 30, and 60 mg/ml. The mean percentages of vascularization of CAMs treated with these three extract concentrations were 15.4%, 17.1%, and 17.2%, respectively, which were significantly higher (p<0.05) than that in the negative (8.9%) and inhibitor controls (2.2%). Therefore, it was concluded that the aqueous extract of S. pseudoquina can promote angiogenesis at the concentrations tested.
- 11 December 2023
- Published by Taylor & Francis in Journal of Toxicology and Environmental Health, Part A
- Vol. 87 (5) , 185-198
Tellimagrandin-I and camptothin a exhibit chemopreventive effects in Salmonella enterica serovar Typhimurium strains and human lymphocytes
Tellimagrandin-I (TL) and camptothin A (CA) are ellagitannins widely found in diverse plant species. Numerous studies demonstrated their significant biological activities, which include antitumor, antioxidant, and hepatoprotective properties. Despite this protective profile, the effects of TL and CA on DNA have not been comprehensively investigated. Thus, the aim of this study was to determine the mutagenic and antimutagenic effects attributed to TL and CA exposure on Salmonella enterica serovar Typhimurium strains using the Ames test. In addition, the cytotoxic and genotoxic effects were examined on human lymphocytes, employing both trypan blue exclusion and CometChip assay. The antigenotoxic effect was determined following TL and CA exposure in the presence of co-treatment with doxorubicin (DXR). Our results from the Ames test indicated that TL or CA did not display marked mutagenic activity. However, TL or CA demonstrated an ability to protect DNA against the damaging effects of the mutagens 4-nitroquinoline-1-oxide and sodium azide, thereby exhibiting antimutagenic properties. In relation to human lymphocytes, TL or CA did not induce significant cytotoxic or genotoxic actions on these cells. Further, these ellagitannins exhibited an ability to protect DNA from damage induced by DOX during co-treatment, indicating their potential beneficial usefulness as antigenotoxic agents. In conclusion, the protective effects of TL or CA against mutagens, coupled with their absence of genotoxic and cytotoxic effects on human lymphocytes, emphasize their potential therapeutic value in chemopreventive strategies.
- 11 December 2023
- Published by Taylor & Francis in Journal of Toxicology and Environmental Health, Part A
- Vol. 87 (5) , 185-198
Tellimagrandin-I and camptothin a exhibit chemopreventive effects in Salmonella enterica serovar Typhimurium strains and human lymphocytes
Tellimagrandin-I (TL) and camptothin A (CA) are ellagitannins widely found in diverse plant species. Numerous studies demonstrated their significant biological activities, which include antitumor, antioxidant, and hepatoprotective properties. Despite this protective profile, the effects of TL and CA on DNA have not been comprehensively investigated. Thus, the aim of this study was to determine the mutagenic and antimutagenic effects attributed to TL and CA exposure on Salmonella enterica serovar Typhimurium strains using the Ames test. In addition, the cytotoxic and genotoxic effects were examined on human lymphocytes, employing both trypan blue exclusion and CometChip assay. The antigenotoxic effect was determined following TL and CA exposure in the presence of co-treatment with doxorubicin (DXR). Our results from the Ames test indicated that TL or CA did not display marked mutagenic activity. However, TL or CA demonstrated an ability to protect DNA against the damaging effects of the mutagens 4-nitroquinoline-1-oxide and sodium azide, thereby exhibiting antimutagenic properties. In relation to human lymphocytes, TL or CA did not induce significant cytotoxic or genotoxic actions on these cells. Further, these ellagitannins exhibited an ability to protect DNA from damage induced by DOX during co-treatment, indicating their potential beneficial usefulness as antigenotoxic agents. In conclusion, the protective effects of TL or CA against mutagens, coupled with their absence of genotoxic and cytotoxic effects on human lymphocytes, emphasize their potential therapeutic value in chemopreventive strategies.
- 20 September 2023
- Published by Taylor & Francis in Journal of Toxicology and Environmental Health, Part A
- Vol. 86 (24) , 929-941
Chemopreventive effect and induction of DNA repair by oenothein B ellagitannin isolated from leaves of Eugenia uniflora in Swiss Webster treated mice
Oenothein B (OeB) is a dimeric ellagitannin with potent antioxidative, antitumor, immunomodulatory, and anti-inflammatory properties. Despite the promising activities of OeB, studies examining the genotoxic or protective effects of this ellagitannin on DNA are scarce. Therefore, to further comprehensively elucidate the chemopreventive profile of OeB, the aim of this study was to evaluate the mutagenic and antimutagenic actions of OeB using Salmonella typhimurium strains with the Ames test. The micronucleus (MN) test and comet assay were used to assess the anticytotoxic and antigenotoxic effects of OeB on mouse bone marrow cells following differing treatments (pre-, co-, and post-treatment) in response to cyclophosphamide (CPA)-induced DNA damage. In addition, histopathological analyses were performed to assess liver and kidney tissues of Swiss Webster treated mice. Our results did not detect mutagenic or antimutagenic activity attributed to OeB at any concentration in the Ames test. Regarding the MN test, data showed that this ellagitannin exerted antigenotoxic and anticytotoxic effects against CPA-induced DNA damage under all treatment conditions. However, no anticytotoxic action was observed in MN test after pre-treatment with the highest doses of OeB. In addition, OeB demonstrated antigenotoxic effects in the comet assay for all treatments. Histopathological analyses indicated that OeB attenuated the toxic effects of CPA in mouse liver and kidneys. These findings suggest that OeB exerted a chemoprotective effect following pre- and co-treatments and a DNA repair action in post-treatment experiments. Our findings indicate that OeB protects DNA against CPA-induced damaging agents and induces post-damage DNA repair.
- 20 September 2023
- Published by Taylor & Francis in Journal of Toxicology and Environmental Health, Part A
- Vol. 86 (24) , 929-941
Chemopreventive effect and induction of DNA repair by oenothein B ellagitannin isolated from leaves of Eugenia uniflora in Swiss Webster treated mice
Oenothein B (OeB) is a dimeric ellagitannin with potent antioxidative, antitumor, immunomodulatory, and anti-inflammatory properties. Despite the promising activities of OeB, studies examining the genotoxic or protective effects of this ellagitannin on DNA are scarce. Therefore, to further comprehensively elucidate the chemopreventive profile of OeB, the aim of this study was to evaluate the mutagenic and antimutagenic actions of OeB using Salmonella typhimurium strains with the Ames test. The micronucleus (MN) test and comet assay were used to assess the anticytotoxic and antigenotoxic effects of OeB on mouse bone marrow cells following differing treatments (pre-, co-, and post-treatment) in response to cyclophosphamide (CPA)-induced DNA damage. In addition, histopathological analyses were performed to assess liver and kidney tissues of Swiss Webster treated mice. Our results did not detect mutagenic or antimutagenic activity attributed to OeB at any concentration in the Ames test. Regarding the MN test, data showed that this ellagitannin exerted antigenotoxic and anticytotoxic effects against CPA-induced DNA damage under all treatment conditions. However, no anticytotoxic action was observed in MN test after pre-treatment with the highest doses of OeB. In addition, OeB demonstrated antigenotoxic effects in the comet assay for all treatments. Histopathological analyses indicated that OeB attenuated the toxic effects of CPA in mouse liver and kidneys. These findings suggest that OeB exerted a chemoprotective effect following pre- and co-treatments and a DNA repair action in post-treatment experiments. Our findings indicate that OeB protects DNA against CPA-induced damaging agents and induces post-damage DNA repair.
- Open Access
- 14 March 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (3) , 943
Immunogenic Cell Death Photothermally Mediated by Erythrocyte Membrane-Coated Magnetofluorescent Nanocarriers Improves Survival in Sarcoma Model
Inducing immunogenic cell death (ICD) during cancer therapy is a major challenge that might significantly improve patient survival. The purpose of this study was to develop a theranostic nanocarrier, capable both of conveying a cytotoxic thermal dose when mediating photothermal therapy (PTT) after its intravenous delivery, and of consequently inducing ICD, improving survival. The nanocarrier consists of red blood cell membranes (RBCm) embedding the near-infrared dye IR-780 (IR) and camouflaging Mn-ferrite nanoparticles (RBCm-IR-Mn). The RBCm-IR-Mn nanocarriers were characterized by size, morphology, surface charge, magnetic, photophysical, and photothermal properties. Their photothermal conversion efficiency was found to be size- and concentration-dependent. Late apoptosis was observed as the cell death mechanism for PTT. Calreticulin and HMGB1 protein levels increased for in vitro PTT with temperature around 55 °C (ablative regime) but not for 44 °C (hyperthermia), suggesting ICD elicitation under ablation. RBCm-IR-Mn were then intravenously administered in sarcoma S180-bearing Swiss mice, and in vivo ablative PTT was performed five days later. Tumor volumes were monitored for the subsequent 120 days. RBCm-IR-Mn-mediated PTT promoted tumor regression in 11/12 animals, with an overall survival rate of 85% (11/13). Our results demonstrate that the RBCm-IR-Mn nanocarriers are great candidates for PTT-induced cancer immunotherapy.
- 14 March 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (3) , 943
Open AccessImmunogenic Cell Death Photothermally Mediated by Erythrocyte Membrane-Coated Magnetofluorescent Nanocarriers Improves Survival in Sarcoma Model
Inducing immunogenic cell death (ICD) during cancer therapy is a major challenge that might significantly improve patient survival. The purpose of this study was to develop a theranostic nanocarrier, capable both of conveying a cytotoxic thermal dose when mediating photothermal therapy (PTT) after its intravenous delivery, and of consequently inducing ICD, improving survival. The nanocarrier consists of red blood cell membranes (RBCm) embedding the near-infrared dye IR-780 (IR) and camouflaging Mn-ferrite nanoparticles (RBCm-IR-Mn). The RBCm-IR-Mn nanocarriers were characterized by size, morphology, surface charge, magnetic, photophysical, and photothermal properties. Their photothermal conversion efficiency was found to be size- and concentration-dependent. Late apoptosis was observed as the cell death mechanism for PTT. Calreticulin and HMGB1 protein levels increased for in vitro PTT with temperature around 55 °C (ablative regime) but not for 44 °C (hyperthermia), suggesting ICD elicitation under ablation. RBCm-IR-Mn were then intravenously administered in sarcoma S180-bearing Swiss mice, and in vivo ablative PTT was performed five days later. Tumor volumes were monitored for the subsequent 120 days. RBCm-IR-Mn-mediated PTT promoted tumor regression in 11/12 animals, with an overall survival rate of 85% (11/13). Our results demonstrate that the RBCm-IR-Mn nanocarriers are great candidates for PTT-induced cancer immunotherapy.
- 6 September 2022
- Published by Taylor & Francis in Journal of Toxicology and Environmental Health, Part A
- Vol. 85 (22) , 937-951
Protective effects and DNA repair induction of a coumarin-chalcone hybrid against genotoxicity induced by mutagens
Coumarins and chalcones are compounds widely found in plants or obtained by synthetic methods which possess several biological properties including antioxidant, anti-inflammatory, and antitumor effects. A series of coumarin-chalcone hybrids were synthesized to improve their biological actions and reduce potential adverse effects. Considering the applications of these molecules, a coumarin-chalcone hybrid [7-methoxy-3-(E)-3-(3,4,5-trimethoxyphenyl) acryloyl-2 H-chromen-2-one] (4-MET) was synthesized and the genotoxic, cytotoxic, and protective effects assessed against damage induced by different mutagens. First, in silico tools were used to predict biological activity of 4-MET which indicated a chemopreventive potential. Subsequently, the genotoxic/antigenotoxic activities of 4-MET were determined both in vitro (Ames test) and in vivo (micronucleus (MN) test and comet assay). In addition, molecular docking simulations were performed between 4-MET and glutathione reductase, an important cellular detoxifying enzyme. Our results indicated that 4-MET was not mutagenic in the Ames test; however, when co-treated with sodium azide or 4-nitroquinoline 1-oxide (4-NQO), 4-MET significantly reduced the harmful actions of these mutagens. Except for a cytotoxic effect after 120 hr treatment, 4-MET alone did not produce cytotoxicity or genotoxicity in the MN test and comet assay. Nonetheless, all treatments of 4-MET with cyclophosphamide (CPA) showed a chemoprotective effect against DNA damage induced by CPA. Further, molecular docking analysis indicated a strong interaction between 4-MET and the catalytic site of glutathione reductase. These effects may be related to (1) damage prevention, (2) interaction with detoxifying enzymes, and (3) DNA-repair induction. Therefore, data demonstrated that 4-MET presents a favorable profile to be used in chemopreventive therapies.
- 6 September 2022
- Published by Taylor & Francis in Journal of Toxicology and Environmental Health, Part A
- Vol. 85 (22) , 937-951
Protective effects and DNA repair induction of a coumarin-chalcone hybrid against genotoxicity induced by mutagens
Coumarins and chalcones are compounds widely found in plants or obtained by synthetic methods which possess several biological properties including antioxidant, anti-inflammatory, and antitumor effects. A series of coumarin-chalcone hybrids were synthesized to improve their biological actions and reduce potential adverse effects. Considering the applications of these molecules, a coumarin-chalcone hybrid [7-methoxy-3-(E)-3-(3,4,5-trimethoxyphenyl) acryloyl-2 H-chromen-2-one] (4-MET) was synthesized and the genotoxic, cytotoxic, and protective effects assessed against damage induced by different mutagens. First, in silico tools were used to predict biological activity of 4-MET which indicated a chemopreventive potential. Subsequently, the genotoxic/antigenotoxic activities of 4-MET were determined both in vitro (Ames test) and in vivo (micronucleus (MN) test and comet assay). In addition, molecular docking simulations were performed between 4-MET and glutathione reductase, an important cellular detoxifying enzyme. Our results indicated that 4-MET was not mutagenic in the Ames test; however, when co-treated with sodium azide or 4-nitroquinoline 1-oxide (4-NQO), 4-MET significantly reduced the harmful actions of these mutagens. Except for a cytotoxic effect after 120 hr treatment, 4-MET alone did not produce cytotoxicity or genotoxicity in the MN test and comet assay. Nonetheless, all treatments of 4-MET with cyclophosphamide (CPA) showed a chemoprotective effect against DNA damage induced by CPA. Further, molecular docking analysis indicated a strong interaction between 4-MET and the catalytic site of glutathione reductase. These effects may be related to (1) damage prevention, (2) interaction with detoxifying enzymes, and (3) DNA-repair induction. Therefore, data demonstrated that 4-MET presents a favorable profile to be used in chemopreventive therapies.
- 21 April 2022
- Published by Sciencedomain International
- p. 90-96
Study about American Trypanosomiasis and Chagas Disease: An Approach towards Sexual Transmission
A review of the literature was performed to investigate the routes of transmission of Trypanosoma cruzi parasites and to evaluate the distribution of Chagas disease, which is now found across five continents. Over time, the epidemiological profile of American trypanosomiasis, which is still considered a neglected illness of Latin America's poor, has altered. T. brucei, a blood protozoan, was found in a family research. Cruzi can be sexually transferred from infected males and females to uninfected mates. The fact that Chagas disease can be transmitted sexually, combined with the migration of Chagas disease patients to previously non-endemic nations and increased travel to endemic areas, has public health consequences. To avoid congenital spread, improved blood supply screening and prenatal care are required.
- 21 April 2022
- Published by Sciencedomain International
- p. 90-96
Study about American Trypanosomiasis and Chagas Disease: An Approach towards Sexual Transmission
A review of the literature was performed to investigate the routes of transmission of Trypanosoma cruzi parasites and to evaluate the distribution of Chagas disease, which is now found across five continents. Over time, the epidemiological profile of American trypanosomiasis, which is still considered a neglected illness of Latin America's poor, has altered. T. brucei, a blood protozoan, was found in a family research. Cruzi can be sexually transferred from infected males and females to uninfected mates. The fact that Chagas disease can be transmitted sexually, combined with the migration of Chagas disease patients to previously non-endemic nations and increased travel to endemic areas, has public health consequences. To avoid congenital spread, improved blood supply screening and prenatal care are required.